Cooper Technology

What Cooper Technology does

Shenzhen Cooper Medical Co., Ltd. (Cooper Technology / 库珀医疗) is a Shenzhen-based, privately-held Chinese medical device manufacturer founded in 2004 that designs, develops, and commercializes high-value medical consumables and equipment across eight product lines: urology, drainage, anesthesia, cardiovascular intervention, digestive, tumor (HIPEC), equipment (endoscopy), and other consumables. Its core technologies include precision silicon piezoresistive pressure and temperature sensors, 4K endoscopic camera systems (3840x2160), ureteral stents with full-coverage membranes, nickel-titanium memory-alloy guide wires and occlusion catheters, and hyperthermic intraperitoneal chemotherapy (HIPEC) thermal perfusion circuit components. The company holds a "first-in-China" Class III medical device registration for its drainage catheter portfolio and has cultivated urology products for over 20 years, positioning itself as a domestic import-substitution player against multinational brands.

The company monetizes through direct sale of Class III hardware consumables and equipment to Chinese hospitals via a sales-led model with provincial/regional sales managers covering Jiangxi, Chongqing, Jiangsu, Henan, Zhejiang, Hunan, Sichuan, and Guangdong, supplemented by government tendering and centralized procurement (集采) channels — where Cooper recently announced winning bids across all product categories — and a dedicated overseas sales division exporting to Southeast Asia, Europe, and the United States. Customer segments are primarily hospital urology, oncology/tumor treatment, anesthesia/ICU, and surgical/interventional departments, served through academic conference engagement (CUA, EAU, AUA), CMEF exhibitions, and medical-engineering industry-academia-research collaboration bases. The company operates a corporate group structure: parent Shenzhen Cooper Medical plus wholly-owned subsidiary Esmay Technology (医思美科技, established 2017 — advanced tumor treatment equipment and endoscopes, backed by Softbank China, Bangqin Capital, and Shaanxi Pharmaceutical Holdings), strategic partner/investee Wuzhou Aokesen Technology (奥格森科技 — endoscopic equipment), and minority stake in Hyreal Medical (东锐医疗). Leadership is founder-led under Chairman and General Manager Mao Yanfa (毛延发), with Vice Chairman/Director Xu Ming (徐铭).

Name

Cooper Technology

Legal name

深圳库珀医疗股份有限公司

Website

https://coppercn.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

Shenzhen Cooper Medical is a privately-held Chinese medical device manufacturer producing high-value Class III consumables across urology, drainage, anesthesia, cardiovascular intervention, and HIPEC oncology, sold to hospitals via provincial sales managers, government centralized procurement, and overseas export channels.

Ownership category

akta.pro rank

Headquarters

HQ city

Shenzhen

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Consumables Sales: The company generates revenue through the sale of high-value medical consumables and equipment. Product categories include urology (stents, guide wires, sheaths), drainage catheters, anesthesia supplies (sensors, tubes), cardiovascular intervention products, digestive series, and tumor treatment equipment. Revenue is generated through direct hospital sales via provincial/regional managers, academic conference engagement, government tendering/centralized procurement, and international export sales. The company also manufactures and sells endoscopic equipment systems.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Cooper Technology (Cooper Medical / 深圳库珀医疗股份有限公司) manufactures and sells high-value medical consumables and equipment spanning urology (ureteral stents, guide wires, sheaths), drainage catheters, anesthesia sensors and circuits, cardiovascular intervention products, digestive/ERCP devices, tumor treatment systems (HIPEC), and endoscopic imaging equipment. The portfolio is sold primarily to hospital departments (urology, oncology, surgery, anesthesia, gastroenterology) and distributed through domestic tendering and an overseas division.

Differentiator

Problem solved

Functional benefit

Products and services

• Urology Series (Ureteral Stents, Guide Wires, Sheaths)

Quantifiable outcome

• HIPEC combined with surgery extended median overall survival from 33.9 months to 45.7 months in Stage III epithelial ovarian cancer patients (11.8 month improvement)
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Five partnerships are on record, tiered core and minor.

• 梧州奥格森科技有限公司 (Wuzhou Aokesen Technology Co., Ltd.)coreStrategic or Co-development Partner · 1 June 2022Wuzhou Aokesen Technology is an investment and business partner of Shenzhen Cooper Technology. The two companies cooperate on medical device products and have held joint exhibition activities at medical device shows. Aokesen specializes in medical equipment that complements Cooper's consumables products, enabling bundled solutions for customers. The companies held a successful joint seminar in August 2022.
• 阳江市人民医院 (Yangjiang People's Hospital)coreStrategic or Co-development Partner · 20 November 2021Established a 'Urology and Andrology Product R&D Industry-Academia-Research Cooperation Base' with Yangjiang People's Hospital in November 2021. This partnership focuses on collaborative product development, clinical research, and technology transfer between the company and the hospital's urology department, representing a formal医工联合 (medical-engineering collaboration) arrangement.
• 索玛慈善基金会 (Suoma Charity Foundation)minorOthers · 1 January 2020Cooper Medical partners with the Suoma Charity Foundation since 2020 to operate the 'Cooper Suoma Class' scholarship program for impoverished children in Daliangshan mountains. The program provides long-term financial support for education, with Cooper committing to ongoing sponsorship of children and teachers. The partnership was initiated in 2012 with initial material donations and evolved into a structured scholarship program.
• 深圳医思美科技有限公司 (Shenzhen Esmay Technology Co., Ltd.)coreStrategic or Co-development Partner · 1 January 2017Esmay Technology (医思美科技), established in 2017, is a subsidiary located in the Guangdong-Hong Kong-Macao Greater Bay Area's high-tech biomedical industry center (Shenzhen Longgang Baolong Technology City). The company focuses on developing advanced tumor treatment equipment, medical endoscopes, and related consumables. It has received investments from Softbank China (软银中国), Bangqin Capital (邦勤资本), and Shaanxi Pharmaceutical Holdings (陕药控股). Cooper Group showcases Esmay products at exhibitions as part of the group's comprehensive product portfolio.
• 深圳肖传国医院 (Shenzhen Xiao Chuanguo Hospital)coreStrategic or Co-development Partner · 18 July 2015Shenzhen Xiao Chuanguo Hospital, a national secondary hospital with 200+ beds and 20+ clinical departments, established a partnership with Cooper Medical in 2015. The hospital is led by Professor Xiao Chuanguo, a renowned urologist and inventor of the Xiao reflex arc technique. Professor Xiao highly praised Cooper's drainage, urology, and cardiovascular intervention products. The partnership involves product evaluation, clinical feedback, and collaborative product development discussions. The hospital conducts surgeries using Cooper products and provides feedback for product improvement.

Scale indicators5 records

Recent moves6 records

Expansion highlights3 records

Broad incumbents

• MicroPort Scientific: Hong Kong-listed Chinese medical device group with cardiovascular, orthopedic, and interventional franchises including patient monitoring sensors and disposables — a broader-incumbent comparable on business model and Chinese export orientation.
• Mindray: Largest Chinese medical device incumbent with a much broader portfolio spanning patient monitoring, in-vitro diagnostics, and medical imaging — a comparable Chinese-listed medical device company but at substantially larger scale and scope than Cooper.
• Stryker: Diversified global medical device leader with endoscopy, surgical instruments, and urology-adjacent franchises — comparable on multi-specialty hospital sales motion and capital equipment plus consumables business model, though far broader in scope.

Direct peers

• Becton Dickinson (BD): Through its acquisition of C.R. Bard, BD is a leading supplier of urology consumables, drainage catheters, and surgical accessories directly comparable to Cooper's drainage and urology product lines, and is one of the imported brands Cooper is positioning to substitute domestically.
• Karl Storz: Premium endoscopic equipment manufacturer whose rigid and flexible endoscopy systems overlap directly with Cooper's 4K camera systems and the endoscopy portfolio of subsidiary Esmay Technology.
• Coloplast: Specialist in urology and continence care products including ureteral stents and guide wires, with a focused product portfolio closely aligned to Cooper's urology franchise and a similar export-driven international growth model.
• Boston Scientific: Global leader in urology and pelvic health, with a comprehensive portfolio of ureteral stents, guide wires, stone management devices, and endoscopic equipment that directly competes with Cooper's core urology franchise in both domestic import-substitution and international export markets.
• Cook Medical: Major multinational in urology interventional devices and drainage catheters, including ureteral stents, guide wires, and percutaneous nephrolithotomy accessories — the same clinical categories Cooper targets for hospital procurement wins.
• Olympus: Global leader in endoscopic imaging systems, including 4K surgical camera platforms that compete directly with Cooper's 4K endoscopic camera system and integrated endoscopy product line.
• Sonoscape: Chinese domestic competitor in endoscopy and minimally invasive surgical imaging, providing a regional direct peer against Cooper's integrated endoscopic camera systems for both hospital procurement and export channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cooper Technology